| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,243 |
6,784 |
$472K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
3,587 |
3,456 |
$134K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,266 |
1,264 |
$105K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,011 |
1,896 |
$103K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,040 |
1,039 |
$87K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
807 |
778 |
$63K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
660 |
660 |
$60K |
| 92587 |
|
1,616 |
1,609 |
$50K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
524 |
493 |
$50K |
| 90461 |
|
1,310 |
1,301 |
$43K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
4,125 |
4,111 |
$43K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
4,302 |
4,272 |
$39K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
348 |
337 |
$29K |
| 99177 |
|
1,984 |
1,983 |
$29K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,113 |
1,108 |
$23K |
| 90620 |
|
62 |
62 |
$14K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
825 |
806 |
$10K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
361 |
335 |
$10K |
| 87634 |
|
98 |
95 |
$6K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
196 |
189 |
$6K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
327 |
311 |
$5K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
34 |
34 |
$5K |
| 83655 |
|
387 |
384 |
$4K |
| 0071A |
|
72 |
72 |
$3K |
| 0072A |
|
69 |
69 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
159 |
156 |
$2K |
| 85018 |
|
875 |
871 |
$2K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
12 |
12 |
$1K |
| 99484 |
|
29 |
28 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
237 |
236 |
$470.99 |
| 96127 |
|
33 |
33 |
$338.91 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
26 |
26 |
$314.88 |
| 99188 |
|
12 |
12 |
$312.00 |
| 87807 |
|
19 |
19 |
$219.45 |
| 82465 |
|
40 |
40 |
$176.14 |
| 90785 |
|
14 |
13 |
$162.54 |